Inventor · disambiguated record
Mark L. Tykocinski
Also filed as: TYKOCINSKI MARK L
20 granted patents·14 pending applications·371 citations·filing 1991–2024
95Inventor score
Files withUNIV JEFFERSON12TYKOCINSKI MARK L6KAHR MEDICAL LTD4TKB ASSOCIATES LIMITED PARTNER3UNIV PENNSYLVANIA3
Top patents by PatentIndex Score
34 records- 0197US9657082B2PD-L1 and PD-L2-based fusion proteins and uses thereofUNIV JEFFERSON·Filed 2014·Granted May 23, 2017·27 cites·8 claims
- 0294US9834610B2Fusion proteins for modulating regulatory and effector T cellsUNIV JEFFERSON·Filed 2014·Granted Dec 5, 2017·15 cites·6 claims
- 0393US9221895B2OX40/TRAIL fusion proteinsTYKOCINSKI MARK L·Filed 2010·Granted Dec 29, 2015·28 cites·11 claims
- 0493US8039437B2Fn14/TRAIL fusion proteinsUNIV PENNSYLVANIA·Filed 2009·Granted Oct 18, 2011·42 cites·9 claims
- 0591US8329657B2Fn14/TRAIL fusion proteins and method of treating cancerTYKOCINSKI MARK L·Filed 2011·Granted Dec 11, 2012·31 cites·8 claims
- 0689US7569663B2Chimeric proteins and methods for using the sameTYKOCINSKI MARK L·Filed 2001·Granted Aug 4, 2009·64 cites·3 claims
- 0785US5242687AMethod of reducing cellular immune response involving T-cells using CD8-bearing antigen presenting cellsTKB ASSOCIATES LIMITED PARTNER·Filed 1991·Granted Sep 7, 1993·85 cites·7 claims
- 0884US9873747B2Fusion proteins that facilitate cancer cell destructionUNIV JEFFERSON·Filed 2014·Granted Jan 23, 2018·3 cites·10 claims
- 0983US7435585B2Auto-stimulating cells and methods for making and using the sameUNIV PENNSYLVANIA·Filed 2002·Granted Oct 14, 2008·13 cites·23 claims
- 1082US11702458B2PD1-41BBL fusion protein and methods of use thereofKAHR MEDICAL LTD·Filed 2018·Granted Jul 18, 2023·2 cites·24 claims
- 1181US6316256B1Method for protein transferTR ASSOCIATES L L C·Filed 2000·Granted Nov 13, 2001·12 cites·22 claims
- 1279US12378322B2Fusion proteins that facilitate cancer cell destructionUNIV JEFFERSON·Filed 2022·Granted Aug 5, 2025·0 cites·14 claims
- 1379US10364279B2PD-L1 and PD-L2-based fusion proteins and uses thereofUNIV JEFFERSON·Filed 2017·Granted Jul 30, 2019·1 cites·9 claims
- 1474US2025115673A1Agonist fusion protein for cd40 and ox40 and uses thereofUNIV JEFFERSON·Filed 2024·Application pending·0 cites
- 1571US2024010700A1Pd1-41bbl fusion protein and methods of use thereofKAHR MEDICAL LTD·Filed 2023·Application pending·0 cites
- 1670US10533054B2Agonist fusion protein for CD40 and OX40 and methods of stimulating the immune systemUNIV JEFFERSON·Filed 2014·Granted Jan 14, 2020·1 cites·13 claims
- 1767US5623056ACDS derivatives and methods of use for cellular modulation and enhancement of cellular engraftmentTKB ASSOCIATES LIMITED PARTNER·Filed 1993·Granted Apr 22, 1997·24 cites·25 claims
- 1865US11332539B2Fusion proteins that facilitate cancer cell destructionUNIV JEFFERSON·Filed 2017·Granted May 17, 2022·0 cites·9 claims
- 1965US2019330305A1Pd-l1 and pd-l2-based fusion proteins and uses thereofUNIV JEFFERSON·Filed 2019·Application pending·0 cites
- 2060US2020239584A1Agonist fusion protein for cd40 and ox40 and uses thereofUNIV JEFFERSON·Filed 2019·Application pending·0 cites
- 2160US2011041190A1Novel chimeric proteinsTYKOCINSKI MARK L·Filed 2009·Application pending·0 cites
- 2258US6797489B2PP14 fusion proteins and methods for making and using the sameTR ASSOCIATES L L C·Filed 2001·Granted Sep 28, 2004·1 cites·26 claims
- 2357US2004161806A1Cells having transferred proteins, and methods of use thereofFiled 2004·Application pending·0 cites
- 2456US5601828ACD8 derivatives and methods of use for cellular modulation and enhancement of cellular engraftmentTKB ASSOCIATES LIMITED PARTNER·Filed 1993·Granted Feb 11, 1997·20 cites·26 claims
- 2556US2014227315A1Novel Chimeric Proteins and Methods for Using The SameUNIV PENNSYLVANIA·Filed 2014·Application pending·0 cites
- 2655US2013243697A1Novel Chimeric Proteins and Methods for Using The SameTYKOCINSKI MARK L·Filed 2012·Application pending·0 cites
- 2753US2018079821A1Fusion Proteins for Modulating Regulatory and Effector T CellsUNIV JEFFERSON·Filed 2017·Application pending·0 cites
- 2852US2024076346A1Type i membrane proteins heterodimers and methods of use thereofKAHR MEDICAL LTD·Filed 2021·Application pending·0 cites
- 2951US2002037583A1Methods for protein transferFiled 2001·Application pending·0 cites
- 3050US12497439B2Multi-functional fusion proteins and uses thereofUNIV JEFFERSON·Filed 2020·Granted Dec 16, 2025·0 cites·1 claims
- 3150US2022267409A1Heterodimers and methods of use thereofKAHR MEDICAL LTD·Filed 2020·Application pending·0 cites
- 3250US2013065815A1Fn 14/TRAIL Fusion ProteinsTYKOCINSKI MARK L·Filed 2012·Application pending·0 cites
- 3349US2005096271A1PP14 fusion proteins and methods for making and using the sameFiled 2004·Application pending·0 cites
- 3417US6420172B1Method for inducing tumor immunityTIB COMPANY LLC·Filed 1992·Granted Jul 16, 2002·2 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Mark L. Tykocinski files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →